Web Stats Provided By Google Analytics

Tuesday, April 15, 2014

BMS Files Reyataz-Cobicistat Combo Tablet NDA For HIV-1

Bristol-Myers Squibb announced the filing of a New Drug Application for the fixed-dose combination tablet of atazanavir sulfate with cobicistat for the treatment of patients with HIV-1.

http://ift.tt/1qFnfMc
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)